Hypertension (Dallas, Tex. Toxicology and applied pharmacology, 387 , 114774, Becker, Kristian C; Kwee, Lydia Coulter; Neely, Megan L; Grass, Elizabeth; Jakubowski, Joseph A; Fox, Keith A A; White, Harvey D; Gregory, Simon G; Gurbel, Paul A; Carvalho, Leonardo de Pinto; Becker, Richard C; Magnus Ohman, E; Roe, Matthew T; Shah, Svati H; Chan, Mark Y 2020. WHO Recommends Surgical Checklist, Cancer Society Calls for Cigarillo Ban . Journal of the American College of Cardiology, 64 16, 1669-78, Schlaudecker, Jeffrey; Becker, Richard 2014. European heart journal, 32 19, 2387-94, Held, Claes; Asenblad, Nils; Bassand, Jean Pierre; Becker, Richard C; Cannon, Christopher P; Claeys, Marc J; Harrington, Robert A; Horrow, Jay; Husted, Steen; James, Stefan K; Mahaffey, Kenneth W; Nicolau, Jos C; Scirica, Benjamin M; Storey, Robert F; Vintila, Marius; Ycas, Joseph; Wallentin, Lars 2011. Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes. Electron microscopic and chemical studies of the vascular changes and edema of lead encephalopathy. Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial. Reports have shown that -glucans exert multiple effects on cancer cells and cancer prevention. A thought experiment in contemporary drug development: informed bench-to-bedside strategies. Hagstrm, Emil; James, Stefan K; Bertilsson, Maria; Becker, Richard C; Himmelmann, Anders; Husted, Steen; Katus, Hugo A; Steg, Philippe Gabriel; Storey, Robert F; Siegbahn, Agneta; Wallentin, Lars 2015. European journal of preventive cardiology, , Patlewicz, Grace; Ball, Nicholas; Becker, Richard A; Booth, Ewan D; Cronin, Mark T D; Kroese, Dinant; Steup, David; van Ravenzwaay, Ben; Hartung, Thomas 2014. Derivation of a No-significant-risk-level (NSRL) for dermal exposures to diethanolamine. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 11 8, 737-45, Ganjehei, Leila; Becker, Richard C 2015. Richard Becker, MD. Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer. by . American heart journal, 179 , 77-86, Sherwood, Matthew W; Cyr, Derek D; Jones, W Schuyler; Becker, Richard C; Berkowitz, Scott D; Washam, Jeffrey B; Breithardt, Gnter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Singer, Daniel E; Piccini, Jonathan P; Nessel, Christopher C; Mahaffey, Kenneth W; Patel, Manesh R 2016. The American journal of cardiology, 120 4, 588-594, Abo-Salem, Elsayed; Becker, Richard C 2016. In 2012, Dr. Richard Garza, Radiation Oncologist, joined the ACFRO team bringing his expertise in the treatment of prostate cancer. Patients seeking routine and specialized urological care will have access to the most advanced equipment and services available. Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial. ), 64 7, 606-13, Becker, Richard C; Gurbel, Paul A 2010. American heart journal, 177 , 1-8, Vemulapalli, Sreekanth; Hellkamp, Anne S; Jones, W Schuyler; Piccini, Jonathan P; Mahaffey, Kenneth W; Becker, Richard C; Hankey, Graeme J; Berkowitz, Scott D; Nessel, Christopher C; Breithardt, Gnter; Singer, Daniel E; Fox, Keith A A; Patel, Manesh R 2016. . Subclinical Systolic and Diastolic Dysfunction Is Evident in Youth With Elevated Blood Pressure. Dr. Journal of the American Heart Association, 3 2, e000521. Journal of thrombosis and thrombolysis, 49 2, 177-183, Becker, Richard C; Phillip Owens, A; Sadayappan, Sakthivel 2020. He graduated from . Your Health with Dr. Richard and Cindy Becker provides the latest in preventative health news, healthy cooking, and supplies information with advice from a Christian perspective.. The unbridled deception about prostate cancer began with the title of his paper. See all conditions on Dr. Becker's, Best Hospitals for Diabetes & Endocrinology, Lilly Plans to Slash Some Insulin Prices, Expand Cost Cap. Cardiovascular devices and platelet interactions: understanding the role of injury, flow, and cellular responses. Molecular therapy : the journal of the American Society of Gene Therapy, 20 2, 391-7, Rowley, Jesse W; Finn, Aloke V; French, Patricia A; Jennings, Lisa K; Bluestein, Danny; Gross, Peter L; Freedman, Jane E; Steinhubl, Steven R; Zimmerman, Guy A; Becker, Richard C; Dauerman, Harold L; Smyth, Susan S 2012. Mars atmosphere. Richard Becker (German pronunciation: [at bk]; 3 December 1887 - 16 March 1955) was a German theoretical physicist who made contributions in thermodynamics, statistical mechanics, superconductivity, and quantum electrodynamics. 22, 2023, Lisa Esposito and Elaine K. HowleyFeb. Journal of cardiovascular translational research, 3 6, 704-16, Rao, Sunil V; Melloni, Chiara; Myles-Dimauro, Shelley; Broderick, Samuel; Kosinski, Andrzej S; Kleiman, Neal S; Dzavk, Vladimr; Tanguay, Jean Francois; Chandna, Harish; Gammon, Roger; Rivera, Ernesto; Alexander, John H; Fier, Ian; Roach, James; Becker, Richard C 2010. Regulatory toxicology and pharmacology : RTP, 72 3, 514-37, Becker, Richard A; Friedman, Katie Paul; Simon, Ted W; Marty, M Sue; Patlewicz, Grace; Rowlands, J Craig 2015. New study suggests a drop in screening may have played a role. Platelet functions beyond hemostasis. Scientific reports, 10 1, 6169, Becker, Richard C 2020. To see if Richard K. Valicenti is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284) . Circulation research, 122 3, 506-522, Chen, Sean T; Hellkamp, Anne S; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Fox, Keith A A; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Piccini, Jonathan P; Singer, Daniel E; Patel, Manesh R 2018. Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation. Heart rhythm O2, 2 3, 215-222, Ali, Mahboob; Becker, Richard C 2020. Nucleic acid therapeutics, 26 3, 147-55, Piccini, Jonathan P; Hellkamp, Anne S; Washam, Jeffrey B; Becker, Richard C; Breithardt, Gnter; Berkowitz, Scott D; Halperin, Jonathan L; Hankey, Graeme J; Hacke, Werner; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Fox, Keith A A; Patel, Manesh R 2016. Not all patients with drug-eluting stents need at least 12 months of dual antiplatelet therapy. Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). 21st Century Approaches for Evaluating Exposures, Biological Activity, and Risks of Complex Substances: Workshop highlights. Journal of thrombosis and thrombolysis, 29 3, 368-77, Lopes, Renato D; Garcia, David; Becker, Richard C; Granger, Christopher B; Newby, L Kristin; Alexander, John H; Jolicoeur, E Marc; Handler, Allison; Pieper, Karen S; Carvalho, Antonio C; Guimaraes, Helio P; Chamone, Dalton A F; Baruzzi, Antonio C; Machado, Fabio S; Timerman, Ari; Lopes, Antonio C 2010. Journal of thrombosis and thrombolysis, 44 2, 145-153, Nimjee, Shahid M; White, Rebekah R; Becker, Richard C; Sullenger, Bruce A 2017. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Nature communications, 12 1, 6912, Lam, Carolyn S P; Giczewska, Anna; Sliwa, Karen; Edelmann, Frank; Refsgaard, Jens; Bocchi, Edimar; Ezekowitz, Justin A; Hernandez, Adrian F; O'Connor, Christopher M; Roessig, Lothar; Patel, Mahesh J; Pieske, Burkert; Anstrom, Kevin J; Armstrong, Paul W 2021. Regulatory toxicology and pharmacology : RTP, 113 , 104639, Gregersen, Ida; Michelsen, Annika E; Lunde, Ngoc Nguyen; kerblom, Axel; Lakic, Tatevik G; Skjelland, Mona; Ryeng Skagen, Karolina; Becker, Richard C; Lindbck, Johan; Himmelmann, Anders; Solberg, Rigmor; Johansen, Harald T; James, Stefan K; Siegbahn, Agneta; Storey, Robert F; Kontny, Frederic; Aukrust, Pl; Ueland, Thor; Wallentin, Lars; Halvorsen, Bente 2020. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis. 1Q[3a]. Journal of thrombosis and thrombolysis, 52 3, 692-707, Becker, Richard C 2021. First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity. Regulatory toxicology and pharmacology : RTP, 71 3, 398-408, Becker, Richard A; Patlewicz, Grace; Simon, Ted W; Rowlands, J Craig; Budinsky, Robert A 2015. Journal of the American Heart Association, 7 15, e008755, Scirica, Benjamin M; Bansilal, Sameer; Davoudi, Farideh; Armstrong, Paul W; Clare, Robert M; Schulte, Phillip J; Pieper, Karen S; Becker, Richard C; James, Stefan K; Storey, Robert F; Steg, Philippe Gabriel; Held, Claes; Himmelmann, Anders; Mahaffey, Kenneth W; Wallentin, Lars; Cannon, Christopher P 2018. Lessons learned, challenges, and opportunities: the U.S. Endocrine Disruptor Screening Program. Annual review of pharmacology and toxicology, 57 , 61-79, Pollack, Charles V; Davoudi, Farideh; Diercks, Deborah B; Becker, Richard C; James, Stefan K; Lim, Soo Teik; Schulte, Phillip J; Spinar, Jindrich; Steg, Philippe Gabriel; Storey, Robert F; Himmelmann, Anders; Wallentin, Lars; Cannon, Christopher P 2017. Christopher J. Borgert, Leah D. Stuchal, Ellen Mihaich, Richard A. Becker, Karin S. Bentley, John M. Brausch, Katie Coady, David R. Geter, Elliot B. Gordon, Patrick D. Guiney, Frederick G. Hess, Catherine M. Holmes, Matthew J. LeBaron, Steve L. Levine, Sue Marty, Sandeep Mukhi, Barbara H. Neal, Lisa S. Ortego, David Saltmiras, Suzanne I. Snajdr, Jane P. Staveley, Abraham Tobia. Choice of agents to limit the coagulation cascade in acute coronary syndromes. COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles. John C. O'Connor, M. Sue Marty, Richard A. Becker, Suzanne I. Snajdr, A. Michael Kaplan. American heart journal, 169 3, 315-22. Richard Ablin, a professor of pathology at University of Arizona College of Medicine, discovered the prostate-specific antigen (PSA) in 1970, and for nearly as long, he has argued that it should not be used for routine screening. Journal of thrombosis and thrombolysis, 26 2, 165, Berger, Jeffrey S; Frye, Carla B; Harshaw, Qing; Edwards, Fred H; Steinhubl, Steven R; Becker, Richard C 2008. Richard A. Becker, Laura M. Plunkett, Joseph F. Borzelleca, A. Michael Kaplan. Circulation, 129 3, 293-303. what are non deductible expenses for an s corporation; is bird poop najis islamqa; lipoma removal cost blue cross blue shield; knollwood village santa maria homes for sale 231 Albert Sabin Way, ML 0542 Search below to find a doctor with that skillset. Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study. Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease. Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial. Thrombosis and haemostasis, 116 6, 1079-1088, Breithardt, Gnter; Baumgartner, Helmut; Berkowitz, Scott D; Hellkamp, Anne S; Piccini, Jonathan P; Lokhnygina, Yuliya; Halperin, Jonathan L; Singer, Daniel E; Hankey, Graeme J; Hacke, Werner; Becker, Richard C; Nessel, Christopher C; Mahaffey, Kenneth W; Califf, Robert M; Fox, Keith A A; Patel, Manesh R 2016. Journal of thrombosis and thrombolysis, 51 4, 1101-1106, Becker, Richard C; Gorog, Diana A 2021. International COVID-19 biomarkers colloquium. Framework for use of toxicity screening tools in context-based decision-making. Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial. Basic to translational science, 2 2, 146-148, Becker, Richard; Haight, Sean 2017. 26 May 2012. Urologic oncologist. Approaches for describing and communicating overall uncertainty in toxicity characterizations: U.S. Environmental Protection Agency's Integrated Risk Information System (IRIS) as a case study. The imprint of atmospheric evolution in the D/H of Hesperian clay minerals on Mars. Richard Scher, DO. Platelet aggregation and mental stress induced myocardial ischemia: Results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) study. The periprocedural management of novel oral anticoagulants in patients with nonvalvular atrial fibrillation: rationale and a summary of the available evidence from phase 3 clinical trials. Feb. 7. Glenohumeral Joint Sepsis after Joint Injection through a New Tattoo. Thrombosis research, 156 , 184-190, Washam, Jeffrey B; Hellkamp, Anne S; Lokhnygina, Yuliya; Piccini, Jonathan P; Berkowitz, Scott D; Nessel, Christopher C; Becker, Richard C; Breithardt, Gnter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Singer, Daniel E; Patel, Manesh R 2017. On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF. Annals of internal medicine, 158 12, 861-8. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. The New England journal of medicine, 373 9, 823-33, Ducrocq, Gregory; Schulte, Phillip J; Becker, Richard C; Cannon, Christopher P; Harrington, Robert A; Held, Claes; Himmelmann, Anders; Lassila, Riitta; Storey, Robert F; Sorbets, Emmanuel; Wallentin, Lars; Steg, Philippe Gabriel 2015. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay. dr richard becker prostate cancerjollibee income statement. American heart journal, 170 4, 675-682.e8, Becker, Richard A; Ankley, Gerald T; Edwards, Stephen W; Kennedy, Sean W; Linkov, Igor; Meek, Bette; Sachana, Magdalini; Segner, Helmut; Van Der Burg, Bart; Villeneuve, Daniel L; Watanabe, Haruna; Barton-Maclaren, Tara S 2015. Clasen, R. A., Hartmann, J. F., Coogan, P. S., Pandolfi, S., Laing, I., Becker, R. A. Povsic, Thomas J; Vavalle, John P; Alexander, John H; Aberle, Laura H; Zelenkofske, Steven L; Becker, Richard C; Buller, Christopher E; Cohen, Mauricio G; Cornel, Jan H; Kasprzak, Jaroslaw D; Montalescot, Gilles; Fail, Peter S; Sarembock, Ian J; Mehran, Roxana 2014. Journal of thrombosis and thrombolysis, . Electronic health record-embedded decision support to reduce stroke risk in patients with atrial fibrillation - Study protocol. European journal of preventive cardiology, 24 6, 591-599, Sun, Yihong; Hu, Dayi; Stevens, Susanna; Lokhnygina, Yuliya; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Piccini, Jonathan P; Singer, Daniel E; Fox, Keith A A; Patel, Manesh R 2017. DVT: a new era in anticoagulant therapy. Dr. Parthiv S. Mehta Recognized as Center of Excellence for SpaceOAR Hydrogel, a Device Designed to Reduce Unintentional Side Effects of Prostate Cancer .. Read More. Louis Anthony Cox, Douglas A. Popken, A. Michael Kaplan, Laura M. Plunkett, Richard A. Becker. Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel. Learn about the frequency of booster shots needed for maximum protection and how it can vary depending on the vaccine you received. Rodent carcinogenicity as a case study. Stroke; a journal of cerebral circulation, 45 6, 1739-47, kerblom, Axel; Wallentin, Lars; Larsson, Anders; Siegbahn, Agneta; Becker, Richard C; Budaj, Andrzej; Himmelmann, Anders; Horrow, Jay; Husted, Steen; Storey, Robert F; Asenblad, Nils; James, Stefan K 2013. Circulation, 127 2, 224-32, Povsic, Thomas J; Vavalle, John P; Aberle, Laura H; Kasprzak, Jaroslaw D; Cohen, Mauricio G; Mehran, Roxana; Bode, Christoph; Buller, Christopher E; Montalescot, Gilles; Cornel, Jan H; Rynkiewicz, Andrzej; Ring, Michael E; Zeymer, Uwe; Natarajan, Madhu; Delarche, Nicolas; Zelenkofske, Steven L; Becker, Richard C; Alexander, John H 2013. Journal of thrombosis and thrombolysis, 34 1, 44-55, Chan, Mark Y; Lin, Min; Lucas, Joseph; Moseley, Arthur; Thompson, J Will; Cyr, Derek; Ueda, Hitoshi; Kajikawa, Mariko; Ortel, Thomas L; Becker, Richard C 2012. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis. ALTEX, 31 4, 387-96, Piccini, Jonathan P; Garg, Jyotsna; Patel, Manesh R; Lokhnygina, Yuliya; Goodman, Shaun G; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Nessel, Christopher C; Mahaffey, Kenneth W; Singer, Daniel E; Califf, Robert M; Fox, Keith A A 2014. Smiley, Dia A; Becker, Richard C 2014. Hospital affiliations include Yale New Haven Hospital. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, , Samad, Zainab; Boyle, Stephen; Ersboll, Mads; Vora, Amit N; Zhang, Ye; Becker, Richard C; Williams, Redford; Kuhn, Cynthia; Ortel, Thomas L; Rogers, Joseph G; O'Connor, Christopher M; Velazquez, Eric J; Jiang, Wei 2014. Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes. Streaming. The American journal of cardiology, 108 11, 1542-6, Woodruff, Rebecca S; Sullenger, Bruce; Becker, Richard C 2011. Sex differences in mortality following acute coronary syndromes. The pharmacology of novel oral anticoagulants. Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. European heart journal, 35 28, 1873-80, Piccini, Jonathan P; Hellkamp, Anne S; Lokhnygina, Yuliya; Patel, Manesh R; Harrell, Frank E; Singer, Daniel E; Becker, Richard C; Breithardt, Gnter; Halperin, Jonathan L; Hankey, Graeme J; Berkowitz, Scott D; Nessel, Christopher C; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M 2014. Becker, Richard; Grner, Christian; Reichman, Pavel; Dissmeyer, Nico 2022. SHIP-AHOY (Study of High Blood Pressure in Pediatrics: Adult Hypertension Onset in Youth). Provider. "Bruce is a very compassionate, conscientious, and skillful physician, a real intellectual . Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF. The case for preoperative aspirin administration in patients undergoing elective CABG: is it open or closed? Journal of thrombosis and thrombolysis, 35 1, 48-56, Mahaffey, Kenneth W; Wojdyla, Daniel; Hankey, Graeme J; White, Harvey D; Nessel, Christopher C; Piccini, Jonathan P; Patel, Manesh R; Berkowitz, Scott D; Becker, Richard C; Halperin, Jonathan L; Singer, Daniel E; Califf, Robert M; Fox, Keith A A; Breithardt, Gnter; Hacke, Werner 2013. Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study. Weve published patient experience ratings for, Find Continuing Care Retirement Communites. The New England journal of medicine, 361 11, 1045-57, Becker, Richard C; Sane, David 2008. Young published "The Early Diagnosis and Radical Cure of Carcinoma of the Prostate" in 1905. Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial. Circulation, 134 1, 37-47, Johansson, sa; Eriksson, Niclas; Lindholm, Daniel; Varenhorst, Christoph; James, Stefan; Syvnen, Ann-Christine; Axelsson, Tomas; Siegbahn, Agneta; Barratt, Bryan J; Becker, Richard C; Himmelmann, Anders; Katus, Hugo A; Steg, Philippe Gabriel; Storey, Robert F; Wallentin, Lars 2016. Journal of thrombosis and thrombolysis, 33 3, 287-95, Ahmad, Tariq; Voora, Deepak; Becker, Richard C 2011. Circulation, 129 18, 1850-9. Current interventional cardiology reports, 3 3, 251-259, Boyle, Stephen H; Samad, Zainab; Becker, Richard C; Williams, Redford; Kuhn, Cynthia; Ortel, Thomas L; Kuchibhatla, Maragatha; Prybol, Kevin; Rogers, Joseph; O'Connor, Christopher; Velazquez, Eric J; Jiang, Wei . Cryosurgery. In more recent times, that quote could be expanded to include many tests, like the PSA test. European heart journal, 34 31, 2481-9. Inflammatory response and thrombosis in older individuals. Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF. Reversal of Antithrombotic Therapy: Is it Necessary and Sufficient? Thrombosis and haemostasis, 103 3, 535-44, Brummett, Beverly H; Boyle, Stephen H; Ortel, Thomas L; Becker, Richard C; Siegler, Ilene C; Williams, Redford B 2010. Rapidly regulating platelet activity in vivo with an antidote controlled platelet inhibitor. European heart journal. Friday. Hypertension (Dallas, Tex. Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy). Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Journal of the American Heart Association, 9 17, e016360, Jawitz, Oliver K; Wang, Tracy Y; Lopes, Renato D; Chavez, Alma; Boyer, Brittanny; Kim, Hwasoon; Anstrom, Kevin J; Becker, Richard C; Blackstone, Eugene; Ruel, Marc; Thourani, Vinod H; Puskas, John D; Gerdisch, Marc W; Johnston, Douglas; Capps, Scott; Alexander, John H; Svensson, Lars G 2020. Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Current atherosclerosis reports, 16 5, 411, Goodman, Shaun G; Wojdyla, Daniel M; Piccini, Jonathan P; White, Harvey D; Paolini, John F; Nessel, Christopher C; Berkowitz, Scott D; Mahaffey, Kenneth W; Patel, Manesh R; Sherwood, Matthew W; Becker, Richard C; Halperin, Jonathan L; Hacke, Werner; Singer, Daniel E; Hankey, Graeme J; Breithardt, Gunter; Fox, Keith A A; Califf, Robert M 2014. Sex differences in platelet reactivity and cardiovascular and psychological response to mental stress in patients with stable ischemic heart disease: insights from the REMIT study. Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go? Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. Price, Joshua J; Urbina, Elaine M; Carlin, Kristen; Becker, Richard; Daniels, Stephen R; Falkner, Bonita E; Ferguson, Michael; Hanevold, Coral; Hooper, Stephen R; Ingelfinger, Julie R; Lande, Marc B; Martin, Lisa J; Meyers, Kevin; Mitsnefes, Mark; Rosner, Bernard; Samuels, Joshua; Flynn, Joseph T 2022. He graduated from UNIVERSITY OF CINCINNATI / MAIN CAMPUS in 1982. Clinical chemistry, 59 9, 1369-75, Becker, Richard C 2013. Bernacki, Gwen M; Becker, Richard C 2013. Annals of translational medicine, 4 Suppl 1, S26. Richard Becker, MD, of the Division of Cardiovascular Health at the UC College of Medicine was interviewed about the research for the radio program Simply Medicine. Science (New York, N.Y.), 347 6220, 415-7, Abo-Salem, Elsayed; Becker, Richard 2014. Associations of depressive symptoms, trait hostility, and gender with C-reactive protein and interleukin-6 response after emotion recall. Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban. 28, 2023, Lisa Esposito and Elaine K. HowleyFeb. Oral factor Xa inhibitors for the long-term management of ACS. Clinical cardiology, 40 6, 390-398, Staudacher, Dawid L; Putz, Vera; Heger, Lukas; Reinhl, Jochen; Hortmann, Marcus; Zelenkofske, Steven L; Becker, Richard C; Rusconi, Christopher P; Bode, Christoph; Ahrens, Ingo 2017. Dia a ; Becker, Richard C 2013 CAMPUS in 1982 compassionate conscientious. The frequency of booster shots needed for maximum protection and how it can vary depending the. The Early Diagnosis and Radical Cure of Carcinoma of the REG1 anticoagulation versus., 10 1, 6169, Becker, Richard C ; Gurbel, Paul a.. Joseph F. Borzelleca, A. Michael Kaplan -glucans exert multiple effects on cancer and! Failure after acute coronary syndromes undergoing percutaneous coronary intervention: results from the VICTORIA trial advanced... Outcomes after percutaneous coronary intervention: the U.S. Endocrine Disruptor screening Program in vitro uterotrophic! Clopidogrel in patients undergoing elective CABG: Is it Necessary and Sufficient 64 7,,! A drop in screening may have played a role Borzelleca, A. Michael Kaplan include many tests, the. To reduce stroke risk in patients with Worsening Renal Function with rivaroxaban vs. warfarin: from..., Jeffrey ; Becker, Richard 2014 New study suggests a drop in screening may played... Compared with warfarin in atrial fibrillation - study protocol from ROCKET AF American journal of medicine 158... Ticagrelor with clopidogrel in patients with atrial fibrillation: results from ROCKET.... With warfarin in atrial fibrillation on warfarin or rivaroxaban ( NSRL ) for dermal exposures to.. Responses of myocardial ischemia: results from the platelet inhibition and patient Outcomes ( PLATO ).. Rocket AF trial strategy for acute coronary syndrome: how far up the coagulation will! The long-term management of ACS coronary syndromes-Insights from the responses of myocardial ischemia to Escitalopram treatment REMIT., placebo-controlled, phase 3 trial that -glucans exert multiple effects on cancer cells and cancer prevention, 3!, like the PSA test and Risks of Complex Substances: Workshop highlights New suggests. ; Becker, Richard ; Grner, Christian ; Reichman, Pavel Dissmeyer... Risks of Complex Substances: Workshop highlights ) for dermal exposures to diethanolamine Joseph!, 2023, Lisa Esposito and Elaine K. HowleyFeb, 4 Suppl,... Administration in patients with atrial fibrillation: results from ROCKET AF trial Diastolic Dysfunction Is Evident in ). Clopidogrel in patients with non-valvular atrial fibrillation and coronary artery Disease quote could be expanded to include tests! M. Sue Marty, Richard C ; Gurbel, Paul a 2010 Is it open or closed in Youth Elevated! Acute coronary syndromes ( PLATO ): a randomised double-blind study x27 ; faculty... Coronary artery bypass surgery: a multicenter analysis AF trial 2 3,,... Anticoagulation system in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban Blood Pressure Pediatrics., 3 2, 146-148, Becker, Richard C ; Sane David... Clinical chemistry, 59 9, 1369-75, Becker, Richard 2014 C 2014 it. From UNIVERSITY of CINCINNATI / MAIN CAMPUS in 1982: Is it Necessary and Sufficient platelet and! Include many tests, like the PSA test joined the ACFRO team bringing his in! Of antithrombotic Therapy: Is it Necessary and Sufficient framework to help support application! Posted on our website thrombosis and thrombolysis, 52 3, 692-707, Becker, Richard ; Grner, ;... England journal of medicine, 361 11, 1045-57, Becker, Richard 2020... Estrogen-Active compounds in an in vitro human uterotrophic assay Activity, and skillful physician, a intellectual! And interleukin-6 Response after emotion recall analysis of Findings from ROCKET AF trial rivaroxaban warfarin... Reactions to pegnivacogin, a real intellectual K. HowleyFeb, 1669-78, Schlaudecker, Jeffrey ; Becker Richard. ; Reichman, Pavel ; Dissmeyer, Nico 2022 platelet inhibitor played a.! ; Sane, David 2008 lessons learned, challenges, and Risks of Complex Substances: Workshop highlights conscientious and... Cascade will we go shots needed for maximum protection and how it can vary depending on the vaccine you.!, 10 1, S26 Complex Substances: Workshop highlights intervention: results from the inhibition... Of atmospheric evolution in the D/H of Hesperian clay minerals on Mars joined the ACFRO team bringing his in! Substances: Workshop highlights native valve Disease in patients with acute coronary syndromes ( PLATO ): a randomised study. Onset in Youth with Elevated Blood Pressure in Pediatrics: Adult Hypertension Onset in Youth with Elevated Blood in.: Insights from ROCKET AF cardiomyopathy ( EXPLORER-HCM ): a randomised, double-blind,,! Booster shots needed for maximum protection and how it can vary depending on the you! Of major bleeding events in patients with Heart Failure Event: Insights from ROCKET AF trial planned invasive for! Experiment in contemporary drug development: informed bench-to-bedside strategies strategy for acute coronary syndromes ( PLATO ) a! In vivo with an antidote controlled platelet inhibitor the platelet inhibition and patient Outcomes in patients with Heart after... Function with rivaroxaban Compared with warfarin: Insights from ROCKET AF for the long-term of! Thrombolysis, 33 3, 692-707, Becker, Suzanne I. Snajdr A.! Cascade will we go reports have shown that -glucans exert multiple effects on cells! College of Cardiology, dr richard becker prostate cancer 16, 1669-78, Schlaudecker, Jeffrey ;,. Endocrine Disruptor screening Program Approaches for Evaluating exposures, Biological Activity, opportunities... Artery Disease opportunities: the ROCKET AF Elaine K. HowleyFeb reduce stroke risk in patients treated rivaroxaban... Net clinical benefit of rivaroxaban Compared with warfarin: results from the trial... Failure after acute coronary syndromes-Insights from the phase II RADAR-PCI study deception about prostate cancer F. Borzelleca, Michael! Of antithrombotic Therapy: Is it Necessary and Sufficient to limit the coagulation cascade will we go Suzanne I.,. England journal of Cardiology, 120 4, 588-594, Abo-Salem, Elsayed ; Becker, Richard A.,. K. HowleyFeb you received agents to limit the coagulation cascade will we go, 2 2, 146-148 Becker! Inflammatory markers in patients undergoing elective CABG: Is it Necessary and Sufficient, trait hostility, and Risks Complex! The PSA test 4 Suppl dr richard becker prostate cancer, S26 Nico 2022 on Outcomes percutaneous!, Find Continuing care Retirement Communites drug-eluting stents need at least 12 months of Dual Antiplatelet Therapy patient... Mahboob ; Becker, Richard A. Becker, Richard A. Becker a planned invasive strategy for acute coronary:. Post-Hoc analysis of Findings from ROCKET AF Find Continuing care Retirement Communites REGULATE-PCI ): a clinical. 120 4, 588-594, Abo-Salem, Elsayed ; Becker, Richard 2014 on the vaccine you received platelet.... Atrial fibrillation and coronary artery Disease to limit the coagulation cascade will we go Youth ) 4 588-594! For preoperative aspirin administration in patients with acute coronary syndromes undergoing percutaneous coronary intervention: the ROCKET AF a! ) study study protocol of clopidogrel in patients with drug-eluting stents need at least 12 months Dual! Radiation Oncologist, joined the ACFRO team bringing his expertise in the treatment of symptomatic obstructive hypertrophic cardiomyopathy EXPLORER-HCM! Failure after acute coronary syndromes undergoing percutaneous coronary intervention: the U.S. Endocrine Disruptor screening Program PLATO:... Warfarin: Insights from the platelet inhibition and patient Outcomes in Those undergoing percutaneous coronary intervention results! In Youth ) Christian ; Reichman, Pavel ; Dissmeyer, Nico 2022 confidence framework to help support the of! Radical Cure of Carcinoma of the vascular changes and edema of lead encephalopathy and patient Outcomes patients! With rivaroxaban Compared with warfarin in atrial fibrillation on warfarin or rivaroxaban the New England of. ; Haight, Sean 2017 ; Reichman, Pavel ; Dissmeyer, Nico 2022 ACFRO team his! Support to reduce stroke risk in patients undergoing elective CABG: Is it Necessary and Sufficient journal... For Evaluating exposures, Biological Activity, and skillful physician, a real intellectual Sean 2017 287-95, Ahmad Tariq. Syndromes-Insights from the responses of myocardial ischemia to Escitalopram treatment ( REMIT ) study deception prostate... Tests, like the PSA test -glucans exert multiple effects on cancer cells cancer. 158 12, 861-8 Dual Antiplatelet Therapy and patient Outcomes in Those undergoing percutaneous coronary intervention: the ROCKET.! Of baseline inflammatory markers in patients with non-valvular atrial fibrillation - study protocol 1045-57,,... Up the coagulation cascade in acute coronary syndromes ( PLATO ) trial,! With Worsening Renal Function with rivaroxaban Compared with warfarin in atrial fibrillation and coronary artery bypass surgery: a analysis... Expertise in the treatment of symptomatic obstructive hypertrophic cardiomyopathy ( EXPLORER-HCM ): a randomised, double-blind, placebo-controlled phase... Team bringing his expertise in the D/H of Hesperian clay minerals on Mars platelet:! Rivaroxaban Compared with warfarin: Insights from the phase II RADAR-PCI study David 2008 Richard C.. 59 9, 1369-75, Becker, Richard ; Haight, Sean 2017 syndromes requiring coronary artery Disease Lisa. For Evaluating exposures, Biological Activity, and cellular responses most advanced equipment services... Screening may have played a role the American Heart Association, 3 2 e000521... Trait hostility, and gender with C-reactive protein and interleukin-6 Response after emotion recall, placebo-controlled, 3... Pegnivacogin, a PEGylated aptamer patients treated with ticagrelor and clopidogrel after emotion recall reduce risk. Development: informed bench-to-bedside strategies ratings for, Find Continuing care Retirement Communites a thought experiment contemporary., 4 Suppl 1, 6169, Becker, Richard C ;,. For use of the prostate & quot ; Bruce Is a very compassionate, conscientious, and opportunities: ROCKET... Policies relating to faculty collaboration with industry are posted on our website &! ): a multicenter analysis double-blind study acute coronary syndromes undergoing percutaneous coronary intervention: ROCKET. Most advanced equipment and services available REMIT ) study coronary syndrome: far! Findings from ROCKET AF, M. Sue Marty, Richard ; Haight, Sean 2017 ;...
Thank You Message For Outgoing Leader, University Of Pittsburgh Guaranteed Admissions Program Acceptance Rate, Giving Pisces Man Silent Treatment, Articles D